AU2003276351A1 - Use of specific inhibitors of tyrosine kinases for immunomodulation - Google Patents

Use of specific inhibitors of tyrosine kinases for immunomodulation

Info

Publication number
AU2003276351A1
AU2003276351A1 AU2003276351A AU2003276351A AU2003276351A1 AU 2003276351 A1 AU2003276351 A1 AU 2003276351A1 AU 2003276351 A AU2003276351 A AU 2003276351A AU 2003276351 A AU2003276351 A AU 2003276351A AU 2003276351 A1 AU2003276351 A1 AU 2003276351A1
Authority
AU
Australia
Prior art keywords
immunomodulation
tyrosine kinases
specific inhibitors
inhibitors
specific
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003276351A
Inventor
Christian Auclair
Thomas Tursz
Laurence Zitvogel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Gustave Roussy (IGR)
Original Assignee
Institut Gustave Roussy (IGR)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Gustave Roussy (IGR) filed Critical Institut Gustave Roussy (IGR)
Publication of AU2003276351A1 publication Critical patent/AU2003276351A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003276351A 2002-09-18 2003-09-17 Use of specific inhibitors of tyrosine kinases for immunomodulation Abandoned AU2003276351A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR02/11545 2002-09-18
FR0211545A FR2844452A1 (en) 2002-09-18 2002-09-18 Modulating dendritic cell activity, e.g. for treatment of viral infections, NK-sensitive tumors or autoimmune diseases, using inhibitors or specific tyrosine kinases, e.g. c-abl, bcr/abl and c-kit
PCT/FR2003/002744 WO2004026311A2 (en) 2002-09-18 2003-09-17 Use of specific inhibitors of tyrosine kinases for immunomodulation

Publications (1)

Publication Number Publication Date
AU2003276351A1 true AU2003276351A1 (en) 2004-04-08

Family

ID=31897468

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003276351A Abandoned AU2003276351A1 (en) 2002-09-18 2003-09-17 Use of specific inhibitors of tyrosine kinases for immunomodulation

Country Status (3)

Country Link
AU (1) AU2003276351A1 (en)
FR (1) FR2844452A1 (en)
WO (1) WO2004026311A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8765777B2 (en) 2004-01-21 2014-07-01 Emory University Compositions and methods of use for tyrosine kinase inhibitors to treat pathogenic infection

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080032989A1 (en) * 2006-05-31 2008-02-07 Robinson William H Method of treating inflammatory diseases using tyroskine kinase inhibitors
WO2016010114A1 (en) * 2014-07-16 2016-01-21 国立大学法人大阪大学 Immunopotentiator potentiating tumor immunity or infection immunity

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69026620T2 (en) * 1989-09-19 1996-10-02 Syntello Inc., San Diego, Calif. ANTI-TUMOR PREPARATION CONTAINING INTERLEUKIN-2 AND HISTAMINE, ANALOGS OR H2-RECEPTOR AGONISTS
WO1994011392A1 (en) * 1992-11-06 1994-05-26 Warner-Lambert Company Peptide inhibitors of tyrosine kinases and therapeutic uses thereof
DE19813760A1 (en) * 1998-03-27 1999-10-07 Gabriele Multhoff Activation of natural killer cells to stimulate immune response, especially in treatment of tumors, infections and autoimmune diseases
JP5004392B2 (en) * 1999-12-22 2012-08-22 スージェン， インク． Method for regulating c-kit tyrosine protein kinase function using indolinone compounds
US20030191048A1 (en) * 2000-08-01 2003-10-09 Mattias Luukkonen Gene expression profile for KSHV infection and methods for treating same
EP1332137B1 (en) * 2000-10-27 2006-03-29 Novartis AG Treatment of gastrointestinal stromal tumors
AU2002235175A1 (en) * 2000-12-06 2002-06-18 Tularik, Inc. Lometrexol combination therapy
EP1471907B1 (en) * 2001-06-29 2008-07-16 AB Science Use of c-kit inhibitors for treating autoimmune diseases

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8765777B2 (en) 2004-01-21 2014-07-01 Emory University Compositions and methods of use for tyrosine kinase inhibitors to treat pathogenic infection

Also Published As

Publication number Publication date
FR2844452A1 (en) 2004-03-19
WO2004026311A2 (en) 2004-04-01
WO2004026311A3 (en) 2004-08-12

Similar Documents

Publication Publication Date Title
AU2003282891A1 (en) Novel tyrosine kinases inhibitors
HK1160859A1 (en) Inhibitors of tyrosine kinases
HK1072545A1 (en) Novel inhibitors of kinases
AU2003251559A1 (en) Heterocyclic inhibitors of kinases
AU2003299651A1 (en) Tyrosine kinase inhibitors
PL377825A1 (en) Diaminotriazoles useful as inhibitors of protein kinases
AU2002213485A1 (en) Inhibitors of protein kinases
AU2003261434A1 (en) Iminothiazolidinones as inhibitors of hcv replication
AU2002256418A1 (en) Inhibitors of bace
AU2003259749A1 (en) 3-pyrrolyl-pyridopyrazoles and 3-pyrrolyl-indazoles as novel kinase inhibitors
AU2003298942A1 (en) Tyrosine kinase inhibitors
AU2003271566A1 (en) Pyrrolopyrazines as kinase inhibitors
AU2003275282A1 (en) Novel tyrosine kinase inhibitors
AU2003294479A1 (en) Modulation of cytokine-inducible kinase expression
AU2003211093A1 (en) Inhibitors of rgs proteins
AU2003217105A1 (en) Novel of cytokine inhibitors
AU2003227639A1 (en) Methods to predict patient responsiveness to tyrosine kinase inhibitors
AU2003247141A1 (en) 4-anilido substituted quinazolines and use thereof as inhibitors of epidermal growth factor receptor kinases
AU2003210983A1 (en) Kinase inhibitors and methods of use thereof
AU2002306734A1 (en) Inhibitors of plasmepsins
AU2003216322A1 (en) Inhibitors of tubulin polymerization
AU2002338734A1 (en) Use of phosphorodiesterase IV inhibitors
HUP0401641A3 (en) Use of substituted diazonine derivatives as phosphorodiesterase iv inhibitors
AU2003276351A1 (en) Use of specific inhibitors of tyrosine kinases for immunomodulation
AU2002253350A1 (en) 4-aminosulfonylquinazolines and -quinolines as tyrosine kinase inhibitors

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase